Skip to content
Menu

Pelthos Therapeutics Q4 EPS $(6.87) Misses $(4.13) Estimate, Sales $9.389M Beat $9.090M Estimate

Benzinga Newsdesk 8 months ago

EarningsEarnings BeatsEarnings MissesNews

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Pelthos Therapeutics (AMEX:PTHS) reported quarterly losses of $(6.87) per share which missed the analyst consensus estimate of $(4.13) by 66.34 percent. This is a 115.36 percent decrease over losses of $(3.19) per share

Pelthos Therapeutics (AMEX:PTHS) reported quarterly losses of $(6.87) per share which missed the analyst consensus estimate of $(4.13) by 66.34 percent. This is a 115.36 percent decrease over losses of $(3.19) per share from the same period last year. The company reported quarterly sales of $9.389 million which beat the analyst consensus estimate of $9.090 million by 3.29 percent.

Read at benzinga.com